Background Arrow Declarations are declarations regarding the validity of subject-matter (rather than specific patents) and provide accused infringers of legal certainty that their proposed activities will not fall within the scope of any valid patent that may be...
The statement from the Unified Patent Court (UPC) Preparatory Committee indicating that they are currently working under the assumption that the UPC will become operational in December 2017 follows the shock announcement in November 2016 that the UK will proceed with...
Introduction The Cancer Immunotherapy Pilot Program, also known as “Patents 4 Patients”, makes certain US patent applications relating to cancer immunotherapy eligible for special status and examination with the goal of completing prosecution within 12...
Background Article 6(2) of the EU Biotech Directive excludes uses of human embryos for industrial or commercial purposes from patentability[1]. This exclusion does not affect inventions for therapeutic or diagnostic purposes which are applied to the human embryo and...
Article 72 of the European Patent Convention states that an assignment of a European patent application shall be made in writing and shall require the signature of the parties to the contract. Such assignments can be recorded centrally at the EPO for pending...
Changes effective 1 October 2016 Notification of intention to grant The UKIPO is to issue advance notification of grant in order to allow patent applicants the opportunity to file a divisional application without the need to recourse to the current practice of...
Recent Comments